• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质相关唾液酸和CA 19-9作为肾细胞癌肿瘤标志物的意义。

Significance of lipid-associated sialic acid and CA 19-9 as tumor markers for renal cell carcinoma.

作者信息

Echenique J E, Graham S D

机构信息

Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.

出版信息

Urology. 1988 Nov;32(5):397-400. doi: 10.1016/0090-4295(88)90408-6.

DOI:10.1016/0090-4295(88)90408-6
PMID:3188302
Abstract

Numerous neoplasms, including colonic, lung, stomach, and prostate, have been found to have increased concentrations of lipid-associated sialic acid (LASA). CA 19-9 is a carbohydrate antigen found on the membrane surface of pancreatic, gastric, and colonic cancers. A prospective study involving 25 patients (15 males, 10 females) with renal cell carcinoma (RCC) was undertaken to examine the clinical value of these two markers. Patients' ages ranged from twenty-five to seventy-seven years (mean 56 years). The group consisted of 9 Stage I, 1 Stage II, 5 Stage III, and 10 Stage IV patients. Twenty three of the 25 had known disease present when tested. Eleven patients with no known tumor were used as an age-matched control group. Sixteen of the 23 patients with known disease (70%) had elevated LASA values. Nine of the 11 control patients (82%) had normal LASA values. Three of 7 patients with values obtained pre- and post-nephrectomy showed levels returned to normal after nephrectomy; 3 had persistent LASA elevation and were found to have either metastatic or recurrent disease, and 1 had a persistent elevation of his LASA value without known metastatic or recurrent disease. When the 23 patients with known disease were compared according to stage, 62 percent of Stages I and II, 80 percent of Stage III, and 70 percent of Stage IV had elevated LASA values. There was no statistically significant difference between LASA values and tumor stage. CA 19-9 values obtained in 15 of 25 patients with RCC were within normal range.

摘要

人们发现,包括结肠癌、肺癌、胃癌和前列腺癌在内的许多肿瘤中,脂质相关唾液酸(LASA)的浓度都有所增加。CA 19-9是一种在胰腺癌、胃癌和结肠癌膜表面发现的碳水化合物抗原。一项针对25例肾细胞癌(RCC)患者(15例男性,10例女性)的前瞻性研究,旨在检验这两种标志物的临床价值。患者年龄在25岁至77岁之间(平均56岁)。该组包括9例I期、1例II期、5例III期和10例IV期患者。25例患者中有23例在检测时已知患有疾病。11例无已知肿瘤的患者作为年龄匹配的对照组。23例已知疾病的患者中有16例(70%)LASA值升高。11例对照患者中有9例(82%)LASA值正常。7例肾切除术前和术后进行检测的患者中,3例术后LASA水平恢复正常;3例LASA持续升高,被发现有转移或复发性疾病,1例LASA值持续升高,但无已知转移或复发性疾病。根据分期对23例已知疾病的患者进行比较时,I期和II期患者中有62%、III期患者中有80%、IV期患者中有70%的LASA值升高。LASA值与肿瘤分期之间无统计学显著差异。25例RCC患者中有15例的CA 19-9值在正常范围内。

相似文献

1
Significance of lipid-associated sialic acid and CA 19-9 as tumor markers for renal cell carcinoma.脂质相关唾液酸和CA 19-9作为肾细胞癌肿瘤标志物的意义。
Urology. 1988 Nov;32(5):397-400. doi: 10.1016/0090-4295(88)90408-6.
2
CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
Obstet Gynecol. 1989 Sep;74(3 Pt 1):384-7.
3
Lipid associated sialic acid in plasma in patients with advanced carcinoma of the ovaries.晚期卵巢癌患者血浆中的脂质相关唾液酸
Surg Gynecol Obstet. 1989 Apr;168(4):296-301.
4
Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.血清CA-125与脂质相关唾液酸(LASA-P)在监测侵袭性卵巢腺癌患者中的比较。
Gynecol Oncol. 1988 May;30(1):98-103. doi: 10.1016/0090-8258(88)90051-0.
5
Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Cancer. 1992 Nov 15;70(10):2499-503. doi: 10.1002/1097-0142(19921115)70:10<2499::aid-cncr2820701018>3.0.co;2-#.
6
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.血清脂质结合唾液酸作为微小残留肿瘤中的肿瘤标志物。
Bull Soc Sci Med Grand Duche Luxemb. 1989 Mar-Apr;126(1):17-20.
7
Use of serum markers in the diagnosis and management of laryngeal cancer.血清标志物在喉癌诊断与治疗中的应用。
Clin Otolaryngol Allied Sci. 1991 Feb;16(1):90-2. doi: 10.1111/j.1365-2273.1991.tb01950.x.
8
Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
Obstet Gynecol. 1989 Sep;74(3 Pt 1):379-83.
9
The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Tumour Biol. 1992;13(3):121-32. doi: 10.1159/000217755.
10
Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
Gynecol Oncol. 1990 Aug;38(2):181-6. doi: 10.1016/0090-8258(90)90037-l.